Advisory: Alerts on Ethos Technologies' Q2 results wrongly attributed to Atyr Pharma withdrawn
ADVISORY-Alerts on Ethos Technologies' Q2 results wrongly attributed to Atyr Pharma withdrawn Alerts on Ethos Technologies' LIFE.O second-quarter results wrongly attributed to Atyr Pharma ATYR.O were inadvertently published and have been withdrawn.
For the correct set of alerts on Ethos' Q2 earnings, click nFWN4400U6.
STORY_NUMBER: nPLX68GRR2
STORY_DATE: 03/08/2026
STORY_TIME: 08:05 PM GMT
Recent news on aTyr Pharma
See all newsBrief: Atyr Pharma Announces Research Collaboration With Montefiore Einstein
U.S. STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
US STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
U.S. STOCKS ON THE MOVE-CoreWeave, Versant Media, BlackBerry
aTyr rises as FDA aligns on late-stage lung disease study plan